Grail, Inc. (NASDAQ:GRAL) CEO Robert P. Ragusa Sells 123,454 Shares

Grail, Inc. (NASDAQ:GRAL) CEO Robert P. Ragusa sold 123,454 shares of the company’s stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $14.02, for a total value of $1,730,825.08. Following the completion of the transaction, the chief executive officer now owns 612,661 shares in the company, valued at $8,589,507.22. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Grail Stock Performance

Shares of NASDAQ GRAL opened at $14.20 on Friday. The business has a 50-day simple moving average of $14.21. Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $23.36.

Grail (NASDAQ:GRAL) last posted its quarterly earnings data on Tuesday, August 13th. The company reported ($5.30) earnings per share (EPS) for the quarter. The firm had revenue of $31.97 million during the quarter.

Analyst Upgrades and Downgrades

Separately, Guggenheim assumed coverage on Grail in a research note on Thursday. They issued a “neutral” rating on the stock.

Grail Company Profile

GRAIL, Inc, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.